Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin (Primary) ; Cyclophosphamide (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms META1
- 18 May 2018 Biomarkers information updated
- 11 Aug 2013 New trial record